Amarin

AMRNNasdaq Ireland Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$298.043 M

$14.11 -1.74%

Close of 10 Aug 2026

Revenue

$213.6M

#2274 by revenue

Earnings

-$38.8M

Loss-making

Shares outstanding

420,044,022

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations — ranked by market cap

All 501 →

#230Opus GeneticsIRD$304.5M
#231Vanda PharmaceuticalsVNDA$303.5M
#232AmarinAMRN$298.0M
#233Zentalis PharmaceuticalsZNTL$297.4M
#234ImmuneeringIMRX$293.1M

Where these numbers come from

Share counts and financials for Amarin are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 10 Aug 2026. Read the methodology.